We designed an αvβ3 integrin–targeted liposome to load Pa and anti–PD–L1 antibody (αPD–L1) to enhance the accumulation in a low PD–L1 expressing mouse 4T1 breast tumor for combined PDT with PD–L1 blockade therapy (Scheme 1). This evidence concerns the gene CD274 and breast neoplasm.